;PMID: 11986336
;source_file_612.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..35] = [t:0..35]
;1)sentence:[e:40..92] = [t:40..92]
;2)section:[e:96..208] = [t:96..208]
;3)section:[e:212..324] = [t:212..324]
;4)sentence:[e:328..424] = [t:328..424]
;5)sentence:[e:425..575] = [t:425..575]
;6)sentence:[e:576..739] = [t:576..739]
;7)sentence:[e:740..823] = [t:740..823]
;8)sentence:[e:824..915] = [t:824..915]
;9)sentence:[e:916..1168] = [t:916..1168]
;10)sentence:[e:1169..1280] = [t:1169..1280]
;11)sentence:[e:1281..1373] = [t:1281..1373]
;12)sentence:[e:1374..1481] = [t:1374..1481]
;13)sentence:[e:1482..1581] = [t:1482..1581]
;14)sentence:[e:1583..1699] = [t:1583..1699]
;15)sentence:[e:1700..1844] = [t:1700..1844]
;16)section:[e:1848..1893] = [t:1848..1893]

;section 0 Span:0..35
;J Clin Pathol  2002 May;55(5):340-5
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..6] Clin) (NNP:[7..13] Pathol) (CD:[15..19] 2002)
        (NNP:[20..23] May) (::[23..24] ;) (CD:[24..26] 55)
        (-LRB-:[26..27] -LRB-) (CD:[27..28] 5) (-RRB-:[28..29] -RRB-)
        (::[29..30] :) (CD:[30..33] 340) (HYPH:[33..34] -) (CD:[34..35] 5)))

;sentence 1 Span:40..92
;Pancreatic cancer after remote peptic ulcer surgery.
;[40..57]:malignancy:"Pancreatic cancer"
(SENT
  (NP-HLN
    (NP (JJ:[40..50] Pancreatic) (NN:[51..57] cancer))
    (PP-TMP (IN:[58..63] after)
      (NP (JJ:[64..70] remote)
        (NML (JJ:[71..77] peptic) (NN:[78..83] ulcer))
        (NN:[84..91] surgery)))
    (.:[91..92] .)))

;section 2 Span:96..208
;Tascilar M, van Rees BP, Sturm PD, Tytgat GN, Hruban RH, Goodman SN,
;Giardiello  FM, Offerhaus GJ, Tersmette AC.
(SEC
  (FRAG (DT:[96..104] Tascilar) (NNP:[105..106] M) (,:[106..107] ,)
        (NNP:[108..111] van) (NNP:[112..116] Rees) (NNP:[117..119] BP)
        (,:[119..120] ,) (NNP:[121..126] Sturm) (NNP:[127..129] PD)
        (,:[129..130] ,) (NNP:[131..137] Tytgat) (NNP:[138..140] GN)
        (,:[140..141] ,) (NNP:[142..148] Hruban) (NNP:[149..151] RH)
        (,:[151..152] ,) (NNP:[153..160] Goodman) (NNP:[161..163] SN)
        (,:[163..164] ,) (NNP:[165..175] Giardiello) (NNP:[177..179] FM)
        (,:[179..180] ,) (NNP:[181..190] Offerhaus) (NNP:[191..193] GJ)
        (,:[193..194] ,) (NNP:[195..204] Tersmette) (NNP:[205..207] AC)
        (.:[207..208] .)))

;section 3 Span:212..324
;Department of Pathology, Academic Medical Center, University of Amsterdam,
;1105  AZ, Amsterdam, The Netherlands.
(SEC
  (FRAG (NNP:[212..222] Department) (IN:[223..225] of)
        (NNP:[226..235] Pathology) (,:[235..236] ,) (NNP:[237..245] Academic)
        (NNP:[246..253] Medical) (NNP:[254..260] Center) (,:[260..261] ,)
        (NNP:[262..272] University) (IN:[273..275] of)
        (NNP:[276..285] Amsterdam) (,:[285..286] ,) (CD:[287..291] 1105)
        (NNP:[293..295] AZ) (,:[295..296] ,) (NNP:[297..306] Amsterdam)
        (,:[306..307] ,) (DT:[308..311] The) (NNP:[312..323] Netherlands)
        (.:[323..324] .)))

;sentence 4 Span:328..424
;BACKGROUND: Peptic ulcer surgery may carry an increased risk for pancreatic 
;cancer development.
;[393..411]:malignancy:"pancreatic  cancer"
(SENT
  (NP (NN:[328..338] BACKGROUND) (::[338..339] :))
  (S
    (NP-SBJ
      (NML (JJ:[340..346] Peptic) (NN:[347..352] ulcer))
      (NN:[353..360] surgery))
    (VP (MD:[361..364] may)
      (VP (VB:[365..370] carry)
        (NP
          (NP (DT:[371..373] an) (VBN:[374..383] increased) (NN:[384..388] risk))
          (PP (IN:[389..392] for)
            (NP
              (NML (JJ:[393..403] pancreatic) (NN:[405..411] cancer))
              (NN:[412..423] development))))))
    (.:[423..424] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[328..424]::NP:S:

;sentence 5 Span:425..575
;Molecular analysis of K-ras codon 12, frequently mutated in  conventional
;pancreatic cancers, might provide insight into the aetiological  mechanisms.
;[447..452]:gene-rna:"K-ras"
;[453..461]:variation-location:"codon 12"
;[499..517]:malignancy:"pancreatic cancers"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[425..434] Molecular) (NN:[435..443] analysis))
      (PP (IN:[444..446] of)
        (NP
          (NP (NN:[447..452] K-ras)
             (NN:[453..458] codon) (CD:[459..461] 12))
          (,:[461..462] ,)
          (VP
            (ADVP (RB:[463..473] frequently))
            (JJ:[474..481] mutated)
            (NP (-NONE-:[481..481] *))
            (PP (IN:[482..484] in)
              (NP (JJ:[486..498] conventional)
                 (JJ:[499..509] pancreatic) (NNS:[510..517] cancers)))))))
    (,:[517..518] ,)
    (VP (MD:[519..524] might)
      (VP (VB:[525..532] provide)
        (NP
          (NP (NN:[533..540] insight))
          (PP (IN:[541..545] into)
            (NP (DT:[546..549] the) (JJ:[550..562] aetiological)
                (NNS:[564..574] mechanisms))))))
    (.:[574..575] .)))

;sentence 6 Span:576..739
;METHODS: The relative risk of pancreatic cancer was computed by  multivariate
;and person-year analysis in a cohort of 2633 patients who had  undergone
;gastrectomy.
;[606..623]:malignancy:"pancreatic cancer"
(SENT
  (NP (NNS:[576..583] METHODS) (::[583..584] :))
  (S
    (NP-SBJ-3
      (NP (DT:[585..588] The) (JJ:[589..597] relative) (NN:[598..602] risk))
      (PP (IN:[603..605] of)
        (NP (JJ:[606..616] pancreatic) (NN:[617..623] cancer))))
    (VP (VBD:[624..627] was)
      (VP (VBN:[628..636] computed)
        (NP-3 (-NONE-:[636..636] *))
        (PP-MNR (IN:[637..639] by)
          (NP
            (NP (JJ:[641..653] multivariate)
              (NML-2 (-NONE-:[653..653] *P*)))
            (CC:[654..657] and)
            (NP
              (NML (NN:[658..664] person) (HYPH:[664..665] -)
                   (NN:[665..669] year))
              (NML-2 (NN:[670..678] analysis)))))
        (PP (IN:[679..681] in)
          (NP
            (NP (DT:[682..683] a) (NN:[684..690] cohort))
            (PP (IN:[691..693] of)
              (NP
                (NP (CD:[694..698] 2633) (NNS:[699..707] patients))
                (SBAR
                  (WHNP-1 (WP:[708..711] who))
                  (S
                    (NP-SBJ-1 (-NONE-:[711..711] *T*))
                    (VP (VBD:[712..715] had)
                      (VP (VBN:[717..726] undergone)
                        (NP (NN:[727..738] gastrectomy))))))))))))
    (.:[738..739] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[576..739]::NP:S:

;sentence 7 Span:740..823
;Lung cancer risk was analysed as an indirect means of  assessing smoking
;behaviour.
;[740..751]:malignancy:"Lung cancer"
(SENT
  (S
    (NP-SBJ-1
      (NML (NN:[740..744] Lung) (NN:[745..751] cancer))
      (NN:[752..756] risk))
    (VP (VBD:[757..760] was)
      (VP (VBN:[761..769] analysed)
        (NP-1 (-NONE-:[769..769] *))
        (PP (IN:[770..772] as)
          (NP
            (NP (DT:[773..775] an) (JJ:[776..784] indirect)
                (NN:[785..790] means))
            (PP (IN:[791..793] of)
              (S-NOM
                (NP-SBJ (-NONE-:[793..793] *))
                (VP (VBG:[795..804] assessing)
                  (NP (NN:[805..812] smoking) (NN:[813..822] behaviour)))))))))
    (.:[822..823] .)))

;sentence 8 Span:824..915
;K-ras codon 12 mutational analysis was performed on  15 postgastrectomy
;pancreatic cancers.
;[824..829]:gene-rna:"K-ras"
;[830..838]:variation-location:"codon 12"
;[880..914]:malignancy:"postgastrectomy pancreatic cancers"
(SENT
  (S
    (NP-SBJ-1
      (NML (NN:[824..829] K-ras)
         (NN:[830..835] codon) (CD:[836..838] 12))
      (JJ:[839..849] mutational) (NN:[850..858] analysis))
    (VP (VBD:[859..862] was)
      (VP (VBN:[863..872] performed)
        (NP-1 (-NONE-:[872..872] *))
        (PP (IN:[873..875] on)
          (NP (CD:[877..879] 15)
             (JJ:[880..895] postgastrectomy) (JJ:[896..906] pancreatic)
             (NNS:[907..914] cancers)))))
    (.:[914..915] .)))

;sentence 9 Span:916..1168
;RESULTS: There was an overall increased  risk of pancreatic carcinoma of 1.8
;(95% confidence interval, 1.3 to 2.6) five  to 59 years postoperatively,
;which gradually increased to 3.6 at 35 years or  more after surgery (chi(2)
;test for trend, p < 0.05).
;[965..985]:malignancy:"pancreatic carcinoma"
(SENT
  (NP (NNS:[916..923] RESULTS) (::[923..924] :))
  (S
    (NP-SBJ (EX:[925..930] There))
    (VP (VBD:[931..934] was)
      (NP-PRD
        (NP
          (NP (DT:[935..937] an) (JJ:[938..945] overall)
              (VBN:[946..955] increased) (NN:[957..961] risk))
          (PP (IN:[962..964] of)
            (NP (JJ:[965..975] pancreatic) (NN:[976..985] carcinoma)))
          (PP (IN:[986..988] of)
            (NP (CD:[989..992] 1.8)
              (PRN (-LRB-:[993..994] -LRB-)
                (S
                  (NP-SBJ
                    (NML
                      (NML (CD:[994..996] 95) (NN:[996..997] %))
                      (NN:[998..1008] confidence))
                    (NN:[1009..1017] interval))
                  (,:[1017..1018] ,)
                  (NP-PRD
                    (NP (CD:[1019..1022] 1.3))
                    (PP (TO:[1023..1025] to)
                      (NP (CD:[1026..1029] 2.6)))))
                (-RRB-:[1029..1030] -RRB-))))
          (NP-TMP
            (NP
              (QP (CD:[1031..1035] five) (TO:[1037..1039] to)
                  (CD:[1040..1042] 59))
              (NNS:[1043..1048] years))
            (ADVP (RB:[1049..1064] postoperatively))))
        (,:[1064..1065] ,)
        (SBAR
          (WHNP-1 (WDT:[1066..1071] which))
          (S
            (NP-SBJ-1 (-NONE-:[1071..1071] *T*))
            (ADVP (RB:[1072..1081] gradually))
            (VP (VBD:[1082..1091] increased)
              (PP (TO:[1092..1094] to)
                (NP (CD:[1095..1098] 3.6)))
              (PP (IN:[1099..1101] at)
                (NP
                  (NP
                    (QP (CD:[1102..1104] 35))
                    (NNS:[1105..1110] years)
                    (QP (CC:[1111..1113] or) (JJR:[1115..1119] more)))
                  (PP-TMP (IN:[1120..1125] after)
                    (NP (NN:[1126..1133] surgery)))))
              (PRN (-LRB-:[1134..1135] -LRB-)
                (FRAG
                  (NP
                    (NP (NN:[1135..1141] chi-LRB-2-RRB-) (NN:[1142..1146] test))
                    (PP (IN:[1147..1150] for)
                      (NP (NN:[1151..1156] trend))))
                  (,:[1156..1157] ,)
                  (S
                    (NP-SBJ (NN:[1158..1159] p))
                    (VP (SYM:[1160..1161] <)
                      (NP (CD:[1162..1166] 0.05)))))
                (-RRB-:[1166..1167] -RRB-)))))))
    (.:[1167..1168] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[916..1168]::NP:S:

;sentence 10 Span:1169..1280
;Multivariate analysis  indicated that parameters other than postoperative
;interval did not influence  the risk.
(SENT
  (S
    (NP-SBJ (JJ:[1169..1181] Multivariate) (NN:[1182..1190] analysis))
    (VP (VBD:[1192..1201] indicated)
      (SBAR (IN:[1202..1206] that)
        (S
          (NP-SBJ
            (NP (NNS:[1207..1217] parameters))
            (ADJP (JJ:[1218..1223] other)
              (PP (IN:[1224..1228] than)
                (NP (JJ:[1229..1242] postoperative) (NN:[1243..1251] interval)))))
          (VP (VBD:[1252..1255] did) (RB:[1256..1259] not)
            (VP (VB:[1260..1269] influence)
              (NP (DT:[1271..1274] the) (NN:[1275..1279] risk)))))))
    (.:[1279..1280] .)))

;sentence 11 Span:1281..1373
;Lung cancer risk was significantly increased after surgery, but no  time
;trend was observed.
;[1281..1292]:malignancy:"Lung cancer"
(SENT
  (S
    (S
      (NP-SBJ-2
        (NML (NN:[1281..1285] Lung) (NN:[1286..1292] cancer))
        (NN:[1293..1297] risk))
      (VP (VBD:[1298..1301] was)
        (ADVP (RB:[1302..1315] significantly))
        (VP (VBN:[1316..1325] increased)
          (NP-2 (-NONE-:[1325..1325] *))
          (PP-TMP (IN:[1326..1331] after)
            (NP (NN:[1332..1339] surgery))))))
    (,:[1339..1340] ,) (CC:[1341..1344] but)
    (S
      (NP-SBJ-1 (DT:[1345..1347] no) (NN:[1349..1353] time)
                (NN:[1354..1359] trend))
      (VP (VBD:[1360..1363] was)
        (VP (VBN:[1364..1372] observed)
          (NP-1 (-NONE-:[1372..1372] *)))))
    (.:[1372..1373] .)))

;sentence 12 Span:1374..1481
;The spectrum and prevalence of K-ras codon 12 mutations  were comparable to
;conventional pancreatic cancer.
;[1405..1410]:gene-rna:"K-ras"
;[1411..1419]:variation-location:"codon 12"
;[1420..1429]:variation-event:"mutations"
;[1463..1480]:malignancy:"pancreatic cancer"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1374..1377] The) (NN:[1378..1386] spectrum) (CC:[1387..1390] and)
          (NN:[1391..1401] prevalence))
      (PP (IN:[1402..1404] of)
        (NP (NN:[1405..1410] K-ras)
          (NML (NN:[1411..1416] codon) (CD:[1417..1419] 12))
          (NNS:[1420..1429] mutations))))
    (VP (VBD:[1431..1435] were)
      (ADJP-PRD (JJ:[1436..1446] comparable)
        (PP (TO:[1447..1449] to)
          (NP (JJ:[1450..1462] conventional)
             (JJ:[1463..1473] pancreatic) (NN:[1474..1480] cancer)))))
    (.:[1480..1481] .)))

;sentence 13 Span:1482..1581
;CONCLUSIONS: Remote partial  gastrectomy is associated with an increased risk
;of pancreatic cancer.
;[1563..1580]:malignancy:"pancreatic cancer"
(SENT
  (NP (NNS:[1482..1493] CONCLUSIONS) (::[1493..1494] :))
  (S
    (NP-SBJ-1 (JJ:[1495..1501] Remote) (JJ:[1502..1509] partial)
              (NN:[1511..1522] gastrectomy))
    (VP (VBZ:[1523..1525] is)
      (VP (VBN:[1526..1536] associated)
        (NP-1 (-NONE-:[1536..1536] *))
        (PP-CLR (IN:[1537..1541] with)
          (NP
            (NP (DT:[1542..1544] an) (VBN:[1545..1554] increased)
                (NN:[1555..1559] risk))
            (PP (IN:[1560..1562] of)
              (NP (JJ:[1563..1573] pancreatic) (NN:[1574..1580] cancer)))))))
    (.:[1580..1581] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[1482..1581]::NP:S:

;sentence 14 Span:1583..1699
;Postgastrectomy and non-postgastrectomy pancreatic cancers may share similar 
;aetiological factors, such as smoking.
;[1583..1598]...[1623..1641]:malignancy-type:"Postgastrectomy"..."pancreatic
;cancers"
;[1603..1641]:malignancy:"non-postgastrectomy pancreatic cancers"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[1583..1598] Postgastrectomy)
        (NML-1 (-NONE-:[1598..1598] *P*)))
      (CC:[1599..1602] and)
      (NP
        (ADJP (JJ:[1603..1606] non) (HYPH:[1606..1607] -)
              (JJ:[1607..1622] postgastrectomy))
        (NML-1 (JJ:[1623..1633] pancreatic) (NNS:[1634..1641] cancers))))
    (VP (MD:[1642..1645] may)
      (VP (VB:[1646..1651] share)
        (NP
          (NP (JJ:[1652..1659] similar) (JJ:[1661..1673] aetiological)
              (NNS:[1674..1681] factors))
          (,:[1681..1682] ,)
          (PP (JJ:[1683..1687] such) (IN:[1688..1690] as)
            (NP (NN:[1691..1698] smoking))))))
    (.:[1698..1699] .)))

;sentence 15 Span:1700..1844
;However, the neoplastic process in  patients who have undergone gastrectomy
;appears to be accelerated by factors  related to the surgery itself.
(SENT
  (S
    (ADVP (RB:[1700..1707] However))
    (,:[1707..1708] ,)
    (NP-SBJ-1
      (NP (DT:[1709..1712] the) (JJ:[1713..1723] neoplastic)
          (NN:[1724..1731] process))
      (PP-LOC (IN:[1732..1734] in)
        (NP
          (NP (NNS:[1736..1744] patients))
          (SBAR
            (WHNP-2 (WP:[1745..1748] who))
            (S
              (NP-SBJ-2 (-NONE-:[1748..1748] *T*))
              (VP (VBP:[1749..1753] have)
                (VP (VBN:[1754..1763] undergone)
                  (NP (NN:[1764..1775] gastrectomy)))))))))
    (VP (VBZ:[1776..1783] appears)
      (S
        (NP-SBJ-1 (-NONE-:[1783..1783] *))
        (VP (TO:[1784..1786] to)
          (VP (VB:[1787..1789] be)
            (VP (VBN:[1790..1801] accelerated)
              (NP-1 (-NONE-:[1801..1801] *))
              (PP (IN:[1802..1804] by)
                (NP-LGS
                  (NP (NNS:[1805..1812] factors))
                  (VP (JJ:[1814..1821] related)
                    (NP (-NONE-:[1821..1821] *))
                    (PP-CLR (TO:[1822..1824] to)
                      (NP (DT:[1825..1828] the) (NN:[1829..1836] surgery)
                          (PRP:[1837..1843] itself)))))))))))
    (.:[1843..1844] .)))

;section 16 Span:1848..1893
;PMID: 11986336 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1848..1852] PMID) (::[1852..1853] :) (CD:[1854..1862] 11986336)
        (-LRB-:[1863..1864] -LSB-) (NNP:[1864..1870] PubMed) (::[1871..1872] -)
        (NN:[1873..1880] indexed) (IN:[1881..1884] for)
        (NNP:[1885..1892] MEDLINE) (-RRB-:[1892..1893] -RSB-)))
